The polymerase chain reaction (PCR) screening of microdeletions of the Y chromosome has become an important diagnostic step in the work-up of male infertility. However, there is no agreement about how this diagnosis should be performed. There are suggestions that the large variation in deletion frequency reported in the literature could be due to the various selection criteria of the patients analysed, although methodological aspects may play a role as well. As for other genetic diseases, molecular diagnosis of Y chromosome microdeletions should be controlled by adopting strict internal quality control measures and by participating in external quality assessment schemes. Such an external quality assessment project is presently being organized jointly by the European Academy of Andrology and the European Molecular Genetics Quality Network. Three preliminary trials have given a state-of-the-art picture of the diagnostic performance in various European laboratories, showing an overall rate of misdiagnosis of ~5% for both AZFb and AZFc regions, and providing data useful in the generation of guidelines for the molecular diagnosis of Y chromosome microdeletions.

Molecular diagnosis of Y chromosome microdeletions in Europe: State-of-the-art and quality control / Simoni, Manuela. - In: HUMAN REPRODUCTION. - ISSN 0268-1161. - ELETTRONICO. - 16:3(2001), pp. 402-409. [10.1093/humrep/16.3.402]

Molecular diagnosis of Y chromosome microdeletions in Europe: State-of-the-art and quality control

SIMONI, Manuela
2001

Abstract

The polymerase chain reaction (PCR) screening of microdeletions of the Y chromosome has become an important diagnostic step in the work-up of male infertility. However, there is no agreement about how this diagnosis should be performed. There are suggestions that the large variation in deletion frequency reported in the literature could be due to the various selection criteria of the patients analysed, although methodological aspects may play a role as well. As for other genetic diseases, molecular diagnosis of Y chromosome microdeletions should be controlled by adopting strict internal quality control measures and by participating in external quality assessment schemes. Such an external quality assessment project is presently being organized jointly by the European Academy of Andrology and the European Molecular Genetics Quality Network. Three preliminary trials have given a state-of-the-art picture of the diagnostic performance in various European laboratories, showing an overall rate of misdiagnosis of ~5% for both AZFb and AZFc regions, and providing data useful in the generation of guidelines for the molecular diagnosis of Y chromosome microdeletions.
2001
16
3
402
409
Molecular diagnosis of Y chromosome microdeletions in Europe: State-of-the-art and quality control / Simoni, Manuela. - In: HUMAN REPRODUCTION. - ISSN 0268-1161. - ELETTRONICO. - 16:3(2001), pp. 402-409. [10.1093/humrep/16.3.402]
Simoni, Manuela
File in questo prodotto:
File Dimensione Formato  
160402.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 749.55 kB
Formato Adobe PDF
749.55 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/607792
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 64
  • ???jsp.display-item.citation.isi??? 52
social impact